Back to Journals » Drug Design, Development and Therapy » Modern Computational Approaches for Drug Design and Discovery
Drug Design, Development and Therapy
- View all (5535)
- Volume 20, 2026 (304)
- Volume 19, 2025 (762)
- Volume 18, 2024 (430)
- Volume 17, 2023 (283)
- Volume 16, 2022 (316)
- Volume 15, 2021 (399)
- Volume 14, 2020 (477)
- Volume 13, 2019 (387)
- Volume 12, 2018 (382)
- Volume 11, 2017 (330)
- Volume 10, 2016 (374)
- Volume 9, 2015 (543)
- Volume 8, 2014 (231)
- Volume 7, 2013 (143)
- Volume 6, 2012 (42)
- Volume 5, 2011 (40)
- Volume 4, 2010 (35)
- Volume 3, 2009 (27)
- Volume 2, 2008 (29)
- Volume 1, 2007 (1)
Journal Articles:
- Modern Computational Approaches for Drug Design and Discovery (3)
- Advances in p53 Drug Discovery (4)
- Nanotechnology in Drug Delivery for Neurodegenerative Diseases (2)
- New Trends in Formulations for Oral Inhalation (1)
- Exploring Fragment-Based Approaches in Drug Discovery (2)
- Advances in design and development of ophthalmic drugs (9)
- Using Innovative Drug Delivery Systems to Improve the Efficacy and Applicability of Poorly Water-soluble Drugs (4)
- Beyond Brain Boundaries: Overcoming the Blood-Brain Barrier to Reach the Central Nervous System (1)
- A cross-sectional survey on heart failure from China: disease burden and management (3)
- Ten Years of Biosimilars in Europe (4)
Modern Computational Approaches for Drug Design and Discovery
Computer-aided drug design (CADD) is a fundamental component of contemporary drug discovery. CADD methods are generally divided into two main categories: Structure-Based Drug Design (SBDD) and Ligand-Based Drug Design (LBDD). The swift advancements in crystallography and homology modeling have greatly improved structure-based virtual screening, facilitating the effective identification of potential drug candidates in the initial stages of drug discovery. Furthermore, the rise in accessible computational power has enhanced the implementation of traditional in silico drug design and discovery methods, allowing for the rapid screening of extensive chemical libraries. This Collection gathers the most recent advancements in the development and application of computational methods for drug design and discovery, along with their application in preclinical research.

Structure-Based Virtual Screening of New Skp1 Inhibitor Chemotypes Targeting F-Box Binding Interface
Hussain M, Lu Y, Wang GZ, Tariq M, Zhang J, Zhou GB, Liu J
Drug Design, Development and Therapy 2026, 20:578211
Published Date: 30 March 2026

Benchmarking the Structure-Based Virtual Screening Performance of Wild-Type and Resistant PfDHFR Using Docking and Machine Learning Re-Scoring
Hany MS, Ahmed NS, Boeckler FM, Ibrahim TM
Drug Design, Development and Therapy 2025, 19:7045-7058
Published Date: 15 August 2025

Detailed in silico Evaluation of WNV Proteins: Dynamic and Thermodynamic Insights into Doravirine as a Potential Multitarget Agent
Curcio A, Torti C, Quiros-Roldan E, Alcaro S, Artese A
Drug Design, Development and Therapy 2025, 19:11021-11043
Published Date: 12 December 2025
